Not only that, the massive negative retained earnings on this stock are getting worse by the quarter.
JNJ, ABT are among the large cap blood test strip companies.
Additionally, Apple or Samsung may soon come out with a diabetic special watch that monitors sugar and other vital signs nonstop.
Sentiment: Strong Sell
Look at the DE chart. Select "Basic Chart" on the left.
Then click on "Max" and "Linear" and "Candle" at the top.
You can see the normal historical growth rate takes the price of the stock to about $50.
Also you can see massive swings in stock price since 2005.
The massive rise in the stock price is due primarily to growth in China and the housing boom in USA.
Now that China has pretty much copied the entire suite of products, China sales will likely drop.
Prediction: I have no clue in reality. Just a risk avoidance hunch.
Other posters have posted the positive side of the picture and on one thing they are absolutely correct: Long term, DE is a core holding and I do hold the stock. Food is a necessity.
Corn Posts Longest Slump in Six Months; Wheat, Soy Drop
By Jeff Wilson May 20, 2014 3:52 PM ET
Corn futures fell, capping the longest slump since November, on speculation that beneficial weather will boost crops in the U.S., the world’s biggest producer. Soybeans and wheat declined.
Warm, dry weather in the next six days will aid corn seeding from North Dakota to Ohio, Commodity Weather Group LLC said in a report. Planting was 73 percent completed as of May 18, up from 65 percent a year earlier, U.S. Department of Agriculture data showed yesterday. On May 9, the agency forecast that the harvest will rise to a record in 2014.
“Weather looks good for farmers to make excellent progress finishing up planting this week,” Greg Grow, the director of agribusiness at Archer Financial Services Inc. in Chicago, said in a telephone interview. “The warmer temperatures will help corn plants to get off to a very good start.”
Corn futures for July delivery dropped 0.8 percent to close at $4.735 a bushel at 1:15 p.m. on the Chicago Board of Trade. Earlier, the price touched $4.73, the lowest for a most-active contract since since March 4. The grain fell for a fifth straight session, the longest slump since Nov. 7.
There is at least a 65 percent chance of El Nino weather conditions developing later this year, according to the U.S. Climate Prediction Center. That pattern probably will lead to favorable moisture for Midwest crops without sustained heat, Commodity Weather Group in Bethesda, Maryland, said yesterday in a report.
“The market is locking in on the idea that El Nino will lead to a big U.S. crop and lower prices,” Archer’s Grow said. "
Sentiment: Strong Buy
The CEO of HP has compared 3D printing to an “acorn”, saying the technology could possibly “become an oak tree”.
DDD is just that, an acorn sprouting new branches each of which produces a multitude of acorns.
Sentiment: Strong Buy
In fact BAC is a concern to GS due to competition.
Furthermore, the ratio is lower because BAC is lending.
When BAC is lending, it makes more money while rates are low rather than waiting.
Borrow under 2% and lend over 4% and you have 100% operating margin from the get go.
I think HDB is massively overpriced and IBN is undervalued based on p/e and peg ratios.
Is it relatively difficult for other companies to enter the market with competing products that are of equal or greater quality, durability, accuracy? Or, is there a very high bar to entry? Note: I have looked at their offerings and, to me, they appear to be difficult to compete with.
Twitter is now a $24 billion market cap instant messenger service with user tables with pointers.
I think Jorge is referencing the fact that SEC and Justice Departments budgets have been slashed by Congress. Worse, the sequester reduced "policing" even more.
In this economy I have been focused on agriculture stocks for 2 reasons:
1. They generally massively outperform the market.
2. I consider them to be in the necessities category.
SJM Jelly/Jam/Peanut Butter & Coffee.
BG Agriculture commodities around the world since 1818
SFD ham, bacon, etc.
TNH(and other fertilizer companies).
GIS cheerios etc.
BRFS (fastest large cap growth company in the world but not for the faint hearted)
enough for now.
ps: I like India stocks for many reasons, primarily because it is a true capitalist democracy. I worked there for many years in agriculture.
Why doesn't the family just put the company up for sale and be done with it? Best for shareholders and for insiders.
About 250% increase in dividend payout over the past 7 years or average of 35% increase per year sure does make SWY one of the top stockholder friendly companies in the world.
The stock price will, at some point, rise rapidly to reflect that track record once major institutions realize what this company delivers.
I picked up more on this dip and will continue doing so over time. Averaging in has provided excellent rewards over time along with dividends on similar companies.
My conservative projection is at least 40% growth:
Forward P/E : 10.73
Growth (yoy): 40.00% = (Revenue Growth)
PEG ratio based on 40.00% growth = (10.73 / 40) = 0.27
((580 / 0.27) + 117.52) = $2383
IMHO AAPL stock will outperform virtually all other investments over the next 12 months, particlarly in the large cap category.
3 well chosen directors would suffice.
Absolutely no benefit to more than 3 is a crowd.
The positive is insiders are happy with this company based on their activity.
Looks like AxoGen has nothing in the late stage trials pipeline but rather early stage studies.
AxoGen has a couple of clinical trials registered on FDA clinical trials site for which they are recruiting trial patients:
Rank Status Study
1 Recruiting Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer
Peripheral Nerve Injury; Prostate Cancer; Radical Prostatectomy; Nerve Reconstruction; Cavernous Nerve Injury
Other: Processed Human Nerve Tissue Scaffold
2 Recruiting Registry of Avance Nerve Graft Evaluating Utilization and Outcomes for the Reconstruction of Peripheral Nerve Discontinuities
Peripheral Nerve Injuries
Other: Processed Human Nerve Tissue Scaffold; Other: Standard Treatment, Autogenous Nerve Graft, Direct Suture, etc.
TEVA will acquire its way out of patent losses replacing it with even faster growth.
MYL might be one TEVA should consider?
If NFLX makes 76 cents / share next year, what should the stock price be?